These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2654787)

  • 1. GM-CSF treatment in aplasia after cytotoxic therapy.
    Gattringer C; Thaler J; Drach J; Micksche M; Huber H
    Onkologie; 1989 Feb; 12(1):16-8. PubMed ID: 2654787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor.
    Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R
    J Clin Oncol; 1989 Feb; 7(2):159-67. PubMed ID: 2644395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human GM-CSF following chemotherapy in high-risk AML.
    Buechner T; Hiddemann W; Koenigsmann M; Zuehlsdorf M; Woermann B; Boeckmann A; Aguion Freire E; Innig G; Maschmeyer G; Ludwig WD
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():131-4. PubMed ID: 2202465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects.
    Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A
    J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
    Rifkin RM; Hersh EM; Salmon SE
    Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of myelopoiesis in patients with aplastic anemia by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S; Buescher S; Broxmeyer HE; LeMaistre A; Lepe-Zuniga JL; Ventura G; Jeha S; Horwitz LJ; Trujillo JM; Gillis S
    N Engl J Med; 1988 Dec; 319(25):1628-34. PubMed ID: 3059191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of RAEB-t with intensive chemotherapy and GM-CSF.
    Brito-Babapulle F; Lord JA; Whitmore DN
    Leuk Res; 1989; 13(7):605-7. PubMed ID: 2668647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GM-CSF in combination with cytotoxic chemotherapy in AML patients.
    Bettelheim P; Muhm M; Valent P; Geissler K; Andreeff M; Haimi J; Sillaber C; Hinterberger W; Vieder L; Schulz G
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():127-30. PubMed ID: 2202464
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
    Antman KS; Griffin JD; Elias A; Socinski MA; Ryan L; Cannistra SA; Oette D; Whitley M; Frei E; Schnipper LE
    N Engl J Med; 1988 Sep; 319(10):593-8. PubMed ID: 3045544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human granulocyte-macrophage colony stimulating factor (rh GM-CSF) after bone marrow transplantation.
    Link H; Freund M; Kirchner H; Stoll M; Schmid H; Bucsky P; Seidel J; Schulz G; Schmidt RE; Riehm H
    Behring Inst Mitt; 1988 Aug; (83):313-9. PubMed ID: 3071346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
    Cannistra SA; DiCarlo J; Groshek P; Kanakura Y; Berg D; Mayer RJ; Griffin JD
    Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Zittoun R; Suciu S; Mandelli F; de Witte T; Thaler J; Stryckmans P; Hayat M; Peetermans M; Cadiou M; Solbu G; Petti MC; Willemze R
    J Clin Oncol; 1996 Jul; 14(7):2150-9. PubMed ID: 8683249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Administration of granulocyte-macrophage colony growth factors in the treatment of postcytostatic myelosuppresion in oncohematologic patients].
    Neuwirtová R; Sisková M; Kvasnicka J; Cmunt E; Benesová E; Klamová H
    Cas Lek Cesk; 1994 Aug; 133(16):500-4. PubMed ID: 7923328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy for acute leukemias at higher age or after relapse.
    Büchner T; Hiddemann W; Koenigsmann M; Zuehlsdorf M; Woermann B; Boeckmann A; Aguion Freire E; Innig G; Maschmeyer G; Ludwig WD
    Haematol Blood Transfus; 1990; 33():724-31. PubMed ID: 2182462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN; Papadopoulos NE; Chawla SP; Fenoglio C; Cooper S; Buescher ES; Frenck RW; Holian A
    J Clin Oncol; 1992 Aug; 10(8):1266-77. PubMed ID: 1634916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo effect of granulocyte-macrophage colony-stimulating factor on the kinetics of human acute myeloid leukemia cells.
    Aglietta M; De Felice L; Stacchini A; Petti MC; Bianchi AC; Aloe Spiriti MA; Sanavio F; Apra F; Piacibello W; Stern AC
    Leukemia; 1991 Nov; 5(11):979-84. PubMed ID: 1961040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of continuous versus cyclic maintenance chemotherapy on cytokine-induced myeloid colony growth.
    Ridgway D; Borzy MS
    Hematol Pathol; 1990; 4(2):87-92. PubMed ID: 2197267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colony-stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GM-CSF in vivo and interleukin 4 in vitro.
    Millar BC; Bell JB; Millar JL; Treleaven J; Montes A; Joffe JK; Powles RL; McElwain TJ
    Exp Hematol; 1992 Feb; 20(2):209-15. PubMed ID: 1371966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.